Copyright Reports & Markets. All rights reserved.

Global Oncology Devices Market Research Report 2021

Request for Sample of this report
Buy now

1 Oncology Devices Market Overview

  • 1.1 Product Overview and Scope of Oncology Devices
  • 1.2 Oncology Devices Segment by Type
    • 1.2.1 Global Oncology Devices Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Rachytherapy Devices
    • 1.2.3 Endoscopic Devices
  • 1.3 Oncology Devices Segment by Application
    • 1.3.1 Oncology Devices Sales Comparison by Application: (2021-2027)
    • 1.3.2 Cancer Research Institutes
    • 1.3.3 Cancer Hospitals
  • 1.4 Global Oncology Devices Market Size Estimates and Forecasts
    • 1.4.1 Global Oncology Devices Revenue 2016-2027
    • 1.4.2 Global Oncology Devices Sales 2016-2027
    • 1.4.3 Oncology Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Oncology Devices Market Competition by Manufacturers

  • 2.1 Global Oncology Devices Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Oncology Devices Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Oncology Devices Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Oncology Devices Manufacturing Sites, Area Served, Product Type
  • 2.5 Oncology Devices Market Competitive Situation and Trends
    • 2.5.1 Oncology Devices Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Oncology Devices Players Market Share by Revenue
    • 2.5.3 Global Oncology Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Oncology Devices Retrospective Market Scenario by Region

  • 3.1 Global Oncology Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Oncology Devices Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Oncology Devices Market Facts & Figures by Country
    • 3.3.1 North America Oncology Devices Sales by Country
    • 3.3.2 North America Oncology Devices Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Oncology Devices Market Facts & Figures by Country
    • 3.4.1 Europe Oncology Devices Sales by Country
    • 3.4.2 Europe Oncology Devices Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Oncology Devices Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Oncology Devices Sales by Region
    • 3.5.2 Asia Pacific Oncology Devices Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Oncology Devices Market Facts & Figures by Country
    • 3.6.1 Latin America Oncology Devices Sales by Country
    • 3.6.2 Latin America Oncology Devices Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Oncology Devices Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Oncology Devices Sales by Country
    • 3.7.2 Middle East and Africa Oncology Devices Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Oncology Devices Historic Market Analysis by Type

  • 4.1 Global Oncology Devices Sales Market Share by Type (2016-2021)
  • 4.2 Global Oncology Devices Revenue Market Share by Type (2016-2021)
  • 4.3 Global Oncology Devices Price by Type (2016-2021)

5 Global Oncology Devices Historic Market Analysis by Application

  • 5.1 Global Oncology Devices Sales Market Share by Application (2016-2021)
  • 5.2 Global Oncology Devices Revenue Market Share by Application (2016-2021)
  • 5.3 Global Oncology Devices Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 GE Healthcare
    • 6.1.1 GE Healthcare Corporation Information
    • 6.1.2 GE Healthcare Description and Business Overview
    • 6.1.3 GE Healthcare Oncology Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 GE Healthcare Product Portfolio
    • 6.1.5 GE Healthcare Recent Developments/Updates
  • 6.2 Medtronic
    • 6.2.1 Medtronic Corporation Information
    • 6.2.2 Medtronic Description and Business Overview
    • 6.2.3 Medtronic Oncology Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Medtronic Product Portfolio
    • 6.2.5 Medtronic Recent Developments/Updates
  • 6.3 Varian Medical Systems
    • 6.3.1 Varian Medical Systems Corporation Information
    • 6.3.2 Varian Medical Systems Description and Business Overview
    • 6.3.3 Varian Medical Systems Oncology Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Varian Medical Systems Product Portfolio
    • 6.3.5 Varian Medical Systems Recent Developments/Updates
  • 6.4 Elekta
    • 6.4.1 Elekta Corporation Information
    • 6.4.2 Elekta Description and Business Overview
    • 6.4.3 Elekta Oncology Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Elekta Product Portfolio
    • 6.4.5 Elekta Recent Developments/Updates
  • 6.5 Theragenics Corporation
    • 6.5.1 Theragenics Corporation Corporation Information
    • 6.5.2 Theragenics Corporation Description and Business Overview
    • 6.5.3 Theragenics Corporation Oncology Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Theragenics Corporation Product Portfolio
    • 6.5.5 Theragenics Corporation Recent Developments/Updates
  • 6.6 Accuray
    • 6.6.1 Accuray Corporation Information
    • 6.6.2 Accuray Description and Business Overview
    • 6.6.3 Accuray Oncology Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Accuray Product Portfolio
    • 6.6.5 Accuray Recent Developments/Updates
  • 6.7 Elekta
    • 6.6.1 Elekta Corporation Information
    • 6.6.2 Elekta Description and Business Overview
    • 6.6.3 Elekta Oncology Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Elekta Product Portfolio
    • 6.7.5 Elekta Recent Developments/Updates
  • 6.8 Theragenics Corporation
    • 6.8.1 Theragenics Corporation Corporation Information
    • 6.8.2 Theragenics Corporation Description and Business Overview
    • 6.8.3 Theragenics Corporation Oncology Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Theragenics Corporation Product Portfolio
    • 6.8.5 Theragenics Corporation Recent Developments/Updates
  • 6.9 Eckert & Ziegler BEBIG
    • 6.9.1 Eckert & Ziegler BEBIG Corporation Information
    • 6.9.2 Eckert & Ziegler BEBIG Description and Business Overview
    • 6.9.3 Eckert & Ziegler BEBIG Oncology Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Eckert & Ziegler BEBIG Product Portfolio
    • 6.9.5 Eckert & Ziegler BEBIG Recent Developments/Updates

7 Oncology Devices Manufacturing Cost Analysis

  • 7.1 Oncology Devices Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Oncology Devices
  • 7.4 Oncology Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Oncology Devices Distributors List
  • 8.3 Oncology Devices Customers

9 Oncology Devices Market Dynamics

  • 9.1 Oncology Devices Industry Trends
  • 9.2 Oncology Devices Growth Drivers
  • 9.3 Oncology Devices Market Challenges
  • 9.4 Oncology Devices Market Restraints

10 Global Market Forecast

  • 10.1 Oncology Devices Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Oncology Devices by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Oncology Devices by Type (2022-2027)
  • 10.2 Oncology Devices Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Oncology Devices by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Oncology Devices by Application (2022-2027)
  • 10.3 Oncology Devices Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Oncology Devices by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Oncology Devices by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Rachytherapy Devices
    Endoscopic Devices

    Segment by Application
    Cancer Research Institutes
    Cancer Hospitals

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    GE Healthcare
    Medtronic
    Varian Medical Systems
    Elekta
    Theragenics Corporation
    Accuray
    Elekta
    Theragenics Corporation
    Eckert & Ziegler BEBIG

    Buy now